• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund II - Biotechnology Sub-Fund

+ Add to Watchlist

CARBIOA:LX

23.73 EUR

As of 00:00:00 ET on 06/30/2014.

Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)

Year To Date: +14.80% 3-Month: +7.33% 3-Year: +35.55% 52-Week Range: 19.03 - 25.02
1-Month: +6.22% 1-Year: +41.33% 5-Year: +28.76% Beta vs CXBT: -

Mutual Fund Chart for CARBIOA

No chart data available.
  • CARBIOA:LX 23.73
  • 1M
  • 1Y
Interactive CARBIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARBIOA

Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.

Inception Date: 10-10-2000 Telephone: 352-40-40-30-1
Managers: ULF ARVIDSSON
Web Site: www.carnegieam.com

Fundamentals for CARBIOA

NAV (on 2014-06-30) 23.73
Assets (M) (on 2014-06-30) 22.17
Fund Leveraged N
Minimum Investment 15,000.00
Minimum Subsequent Investment -

Dividends for CARBIOA

No dividends reported

Fees & Expenses for CARBIOA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARBIOA

Filing Date: 06/30/2014
Name Position Value % of Total
Celgene Corp 29,600 1,867,114 8.424%
Gilead Sciences Inc 29,000 1,782,575 8.042%
Biogen Idec Inc 7,325 1,701,947 7.678%
Vertex Pharmaceuticals Inc 24,400 1,687,857 7.615%
Alexion Pharmaceuticals Inc 12,100 1,388,790 6.266%
Shire PLC 6,060 1,042,760 4.705%
Salix Pharmaceuticals Ltd 11,200 1,010,180 4.558%
Jazz Pharmaceuticals Plc 8,900 950,966 4.290%
Regeneron Pharmaceuticals Inc 4,600 948,312 4.278%
BioMarin Pharmaceutical Inc 20,600 937,282 4.229%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil